nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—ulcerative colitis	0.334	1	CbGaD
Risedronate—PTGS2—Olsalazine—ulcerative colitis	0.131	0.254	CbGbCtD
Risedronate—PTGS2—Balsalazide—ulcerative colitis	0.116	0.226	CbGbCtD
Risedronate—PTGS2—Mesalazine—ulcerative colitis	0.0931	0.181	CbGbCtD
Risedronate—PTGS2—Sulfasalazine—ulcerative colitis	0.052	0.101	CbGbCtD
Risedronate—PTGS2—Triamcinolone—ulcerative colitis	0.052	0.101	CbGbCtD
Risedronate—PTGS2—Betamethasone—ulcerative colitis	0.0446	0.0867	CbGbCtD
Risedronate—PTGS2—Dexamethasone—ulcerative colitis	0.026	0.0504	CbGbCtD
Risedronate—Histamine Phosphate—SLC22A5—ulcerative colitis	0.00138	1	CrCbGaD
Risedronate—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000821	0.247	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000397	0.119	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.00039	0.118	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.00039	0.118	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000381	0.115	CbGdCrCtD
Risedronate—PTGS2—Overview of nanoparticle effects—CDH3—ulcerative colitis	0.000337	0.111	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000239	0.0721	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000236	0.0709	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000236	0.0709	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.00023	0.0693	CbGdCrCtD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CHP1—ulcerative colitis	0.000204	0.0676	CbGpPWpGaD
Risedronate—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—ulcerative colitis	0.000152	0.0505	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—ulcerative colitis	0.000138	0.0458	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—PRTN3—ulcerative colitis	0.000121	0.0399	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—PTGS1—ulcerative colitis	0.000119	0.0396	CbGpPWpGaD
Risedronate—PTGS2—Eicosanoid Synthesis—PTGS1—ulcerative colitis	9.91e-05	0.0328	CbGpPWpGaD
Risedronate—Arrhythmia—Methylprednisolone—ulcerative colitis	9.8e-05	0.000682	CcSEcCtD
Risedronate—Depression—Prednisone—ulcerative colitis	9.65e-05	0.000672	CcSEcCtD
Risedronate—Mental disorder—Methylprednisolone—ulcerative colitis	9.61e-05	0.000669	CcSEcCtD
Risedronate—Malnutrition—Methylprednisolone—ulcerative colitis	9.55e-05	0.000665	CcSEcCtD
Risedronate—Gastrointestinal pain—Mesalazine—ulcerative colitis	9.54e-05	0.000664	CcSEcCtD
Risedronate—Angioedema—Prednisolone—ulcerative colitis	9.51e-05	0.000662	CcSEcCtD
Risedronate—Dizziness—Budesonide—ulcerative colitis	9.48e-05	0.00066	CcSEcCtD
Risedronate—Hypersensitivity—Azathioprine—ulcerative colitis	9.43e-05	0.000657	CcSEcCtD
Risedronate—Vertigo—Prednisolone—ulcerative colitis	9.35e-05	0.000651	CcSEcCtD
Risedronate—Syncope—Prednisolone—ulcerative colitis	9.33e-05	0.00065	CcSEcCtD
Risedronate—Eye disorder—Dexamethasone—ulcerative colitis	9.32e-05	0.000649	CcSEcCtD
Risedronate—Eye disorder—Betamethasone—ulcerative colitis	9.32e-05	0.000649	CcSEcCtD
Risedronate—Angioedema—Hydrocortisone—ulcerative colitis	9.29e-05	0.000647	CcSEcCtD
Risedronate—Urticaria—Mesalazine—ulcerative colitis	9.27e-05	0.000645	CcSEcCtD
Risedronate—Back pain—Triamcinolone—ulcerative colitis	9.26e-05	0.000644	CcSEcCtD
Risedronate—Abdominal pain—Mesalazine—ulcerative colitis	9.22e-05	0.000642	CcSEcCtD
Risedronate—Body temperature increased—Mesalazine—ulcerative colitis	9.22e-05	0.000642	CcSEcCtD
Risedronate—Loss of consciousness—Prednisolone—ulcerative colitis	9.15e-05	0.000637	CcSEcCtD
Risedronate—Vertigo—Hydrocortisone—ulcerative colitis	9.13e-05	0.000636	CcSEcCtD
Risedronate—Vomiting—Budesonide—ulcerative colitis	9.12e-05	0.000635	CcSEcCtD
Risedronate—Syncope—Hydrocortisone—ulcerative colitis	9.11e-05	0.000635	CcSEcCtD
Risedronate—Angiopathy—Betamethasone—ulcerative colitis	9.05e-05	0.00063	CcSEcCtD
Risedronate—Angiopathy—Dexamethasone—ulcerative colitis	9.05e-05	0.00063	CcSEcCtD
Risedronate—Rash—Budesonide—ulcerative colitis	9.04e-05	0.00063	CcSEcCtD
Risedronate—Dermatitis—Budesonide—ulcerative colitis	9.04e-05	0.000629	CcSEcCtD
Risedronate—Headache—Budesonide—ulcerative colitis	8.99e-05	0.000626	CcSEcCtD
Risedronate—Hypertension—Prednisolone—ulcerative colitis	8.98e-05	0.000625	CcSEcCtD
Risedronate—Loss of consciousness—Hydrocortisone—ulcerative colitis	8.93e-05	0.000622	CcSEcCtD
Risedronate—Arrhythmia—Betamethasone—ulcerative colitis	8.91e-05	0.00062	CcSEcCtD
Risedronate—Arrhythmia—Dexamethasone—ulcerative colitis	8.91e-05	0.00062	CcSEcCtD
Risedronate—Hypertension—Hydrocortisone—ulcerative colitis	8.77e-05	0.000611	CcSEcCtD
Risedronate—Diarrhoea—Azathioprine—ulcerative colitis	8.76e-05	0.00061	CcSEcCtD
Risedronate—Angioedema—Triamcinolone—ulcerative colitis	8.74e-05	0.000609	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—ulcerative colitis	8.73e-05	0.000608	CcSEcCtD
Risedronate—Angioedema—Methylprednisolone—ulcerative colitis	8.72e-05	0.000607	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—ulcerative colitis	8.69e-05	0.000605	CcSEcCtD
Risedronate—FDPS—SREBP signalling—PPARG—ulcerative colitis	8.66e-05	0.0287	CbGpPWpGaD
Risedronate—Myalgia—Hydrocortisone—ulcerative colitis	8.65e-05	0.000602	CcSEcCtD
Risedronate—Anxiety—Hydrocortisone—ulcerative colitis	8.62e-05	0.0006	CcSEcCtD
Risedronate—Vertigo—Triamcinolone—ulcerative colitis	8.6e-05	0.000599	CcSEcCtD
Risedronate—Hypersensitivity—Mesalazine—ulcerative colitis	8.59e-05	0.000598	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	8.59e-05	0.000598	CcSEcCtD
Risedronate—Syncope—Triamcinolone—ulcerative colitis	8.58e-05	0.000597	CcSEcCtD
Risedronate—Vertigo—Methylprednisolone—ulcerative colitis	8.58e-05	0.000597	CcSEcCtD
Risedronate—Syncope—Methylprednisolone—ulcerative colitis	8.56e-05	0.000596	CcSEcCtD
Risedronate—Connective tissue disorder—Prednisone—ulcerative colitis	8.54e-05	0.000594	CcSEcCtD
Risedronate—Nausea—Budesonide—ulcerative colitis	8.52e-05	0.000593	CcSEcCtD
Risedronate—Dizziness—Azathioprine—ulcerative colitis	8.47e-05	0.00059	CcSEcCtD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ulcerative colitis	8.42e-05	0.0279	CbGpPWpGaD
Risedronate—Loss of consciousness—Triamcinolone—ulcerative colitis	8.41e-05	0.000586	CcSEcCtD
Risedronate—Loss of consciousness—Methylprednisolone—ulcerative colitis	8.39e-05	0.000584	CcSEcCtD
Risedronate—Asthenia—Mesalazine—ulcerative colitis	8.37e-05	0.000583	CcSEcCtD
Risedronate—Shock—Prednisolone—ulcerative colitis	8.36e-05	0.000582	CcSEcCtD
Risedronate—Cough—Triamcinolone—ulcerative colitis	8.35e-05	0.000581	CcSEcCtD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—ulcerative colitis	8.29e-05	0.0275	CbGpPWpGaD
Risedronate—Hypertension—Triamcinolone—ulcerative colitis	8.26e-05	0.000575	CcSEcCtD
Risedronate—Pruritus—Mesalazine—ulcerative colitis	8.25e-05	0.000575	CcSEcCtD
Risedronate—Hypertension—Methylprednisolone—ulcerative colitis	8.24e-05	0.000574	CcSEcCtD
Risedronate—Infection—Hydrocortisone—ulcerative colitis	8.24e-05	0.000574	CcSEcCtD
Risedronate—Shock—Hydrocortisone—ulcerative colitis	8.16e-05	0.000568	CcSEcCtD
Risedronate—Myalgia—Triamcinolone—ulcerative colitis	8.15e-05	0.000567	CcSEcCtD
Risedronate—Vomiting—Azathioprine—ulcerative colitis	8.14e-05	0.000567	CcSEcCtD
Risedronate—Nervous system disorder—Hydrocortisone—ulcerative colitis	8.13e-05	0.000566	CcSEcCtD
Risedronate—Arthralgia—Methylprednisolone—ulcerative colitis	8.13e-05	0.000566	CcSEcCtD
Risedronate—Myalgia—Methylprednisolone—ulcerative colitis	8.13e-05	0.000566	CcSEcCtD
Risedronate—Eye disorder—Prednisone—ulcerative colitis	8.12e-05	0.000565	CcSEcCtD
Risedronate—Anxiety—Methylprednisolone—ulcerative colitis	8.1e-05	0.000564	CcSEcCtD
Risedronate—Rash—Azathioprine—ulcerative colitis	8.07e-05	0.000562	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	8.07e-05	0.000562	CcSEcCtD
Risedronate—Dermatitis—Azathioprine—ulcerative colitis	8.07e-05	0.000562	CcSEcCtD
Risedronate—Skin disorder—Hydrocortisone—ulcerative colitis	8.06e-05	0.000561	CcSEcCtD
Risedronate—Headache—Azathioprine—ulcerative colitis	8.02e-05	0.000558	CcSEcCtD
Risedronate—Diarrhoea—Mesalazine—ulcerative colitis	7.98e-05	0.000556	CcSEcCtD
Risedronate—Dry mouth—Triamcinolone—ulcerative colitis	7.97e-05	0.000555	CcSEcCtD
Risedronate—Angioedema—Betamethasone—ulcerative colitis	7.93e-05	0.000552	CcSEcCtD
Risedronate—Angioedema—Dexamethasone—ulcerative colitis	7.93e-05	0.000552	CcSEcCtD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—ulcerative colitis	7.92e-05	0.0262	CbGpPWpGaD
Risedronate—Angiopathy—Prednisone—ulcerative colitis	7.88e-05	0.000549	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—ulcerative colitis	7.85e-05	0.000546	CcSEcCtD
Risedronate—Vertigo—Betamethasone—ulcerative colitis	7.8e-05	0.000543	CcSEcCtD
Risedronate—Vertigo—Dexamethasone—ulcerative colitis	7.8e-05	0.000543	CcSEcCtD
Risedronate—Syncope—Betamethasone—ulcerative colitis	7.79e-05	0.000542	CcSEcCtD
Risedronate—Syncope—Dexamethasone—ulcerative colitis	7.79e-05	0.000542	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—ulcerative colitis	7.76e-05	0.00054	CcSEcCtD
Risedronate—Infection—Triamcinolone—ulcerative colitis	7.76e-05	0.00054	CcSEcCtD
Risedronate—Infection—Methylprednisolone—ulcerative colitis	7.74e-05	0.000539	CcSEcCtD
Risedronate—Dizziness—Mesalazine—ulcerative colitis	7.71e-05	0.000537	CcSEcCtD
Risedronate—Shock—Triamcinolone—ulcerative colitis	7.68e-05	0.000535	CcSEcCtD
Risedronate—Insomnia—Prednisolone—ulcerative colitis	7.68e-05	0.000535	CcSEcCtD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CALM3—ulcerative colitis	7.67e-05	0.0254	CbGpPWpGaD
Risedronate—Shock—Methylprednisolone—ulcerative colitis	7.67e-05	0.000534	CcSEcCtD
Risedronate—Nervous system disorder—Methylprednisolone—ulcerative colitis	7.64e-05	0.000532	CcSEcCtD
Risedronate—Loss of consciousness—Betamethasone—ulcerative colitis	7.63e-05	0.000531	CcSEcCtD
Risedronate—Loss of consciousness—Dexamethasone—ulcerative colitis	7.63e-05	0.000531	CcSEcCtD
Risedronate—Paraesthesia—Prednisolone—ulcerative colitis	7.63e-05	0.000531	CcSEcCtD
Risedronate—Mental disorder—Prednisone—ulcerative colitis	7.61e-05	0.00053	CcSEcCtD
Risedronate—Nausea—Azathioprine—ulcerative colitis	7.61e-05	0.00053	CcSEcCtD
Risedronate—Skin disorder—Methylprednisolone—ulcerative colitis	7.57e-05	0.000527	CcSEcCtD
Risedronate—Malnutrition—Prednisone—ulcerative colitis	7.56e-05	0.000526	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	7.56e-05	0.000526	CcSEcCtD
Risedronate—Insomnia—Hydrocortisone—ulcerative colitis	7.5e-05	0.000522	CcSEcCtD
Risedronate—Hypertension—Dexamethasone—ulcerative colitis	7.5e-05	0.000522	CcSEcCtD
Risedronate—Hypertension—Betamethasone—ulcerative colitis	7.5e-05	0.000522	CcSEcCtD
Risedronate—Paraesthesia—Hydrocortisone—ulcerative colitis	7.45e-05	0.000519	CcSEcCtD
Risedronate—Vomiting—Mesalazine—ulcerative colitis	7.42e-05	0.000516	CcSEcCtD
Risedronate—Myalgia—Dexamethasone—ulcerative colitis	7.39e-05	0.000515	CcSEcCtD
Risedronate—Myalgia—Betamethasone—ulcerative colitis	7.39e-05	0.000515	CcSEcCtD
Risedronate—Anxiety—Betamethasone—ulcerative colitis	7.37e-05	0.000513	CcSEcCtD
Risedronate—Anxiety—Dexamethasone—ulcerative colitis	7.37e-05	0.000513	CcSEcCtD
Risedronate—Rash—Mesalazine—ulcerative colitis	7.35e-05	0.000512	CcSEcCtD
Risedronate—Dermatitis—Mesalazine—ulcerative colitis	7.35e-05	0.000512	CcSEcCtD
Risedronate—Headache—Mesalazine—ulcerative colitis	7.31e-05	0.000509	CcSEcCtD
Risedronate—Dyspepsia—Hydrocortisone—ulcerative colitis	7.3e-05	0.000508	CcSEcCtD
Risedronate—Pain—Prednisolone—ulcerative colitis	7.26e-05	0.000506	CcSEcCtD
Risedronate—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	7.16e-05	0.000499	CcSEcCtD
Risedronate—Fatigue—Hydrocortisone—ulcerative colitis	7.15e-05	0.000498	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	7.12e-05	0.000495	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	7.1e-05	0.000494	CcSEcCtD
Risedronate—Pain—Hydrocortisone—ulcerative colitis	7.09e-05	0.000494	CcSEcCtD
Risedronate—Insomnia—Triamcinolone—ulcerative colitis	7.06e-05	0.000492	CcSEcCtD
Risedronate—Insomnia—Methylprednisolone—ulcerative colitis	7.05e-05	0.000491	CcSEcCtD
Risedronate—Infection—Dexamethasone—ulcerative colitis	7.04e-05	0.00049	CcSEcCtD
Risedronate—Infection—Betamethasone—ulcerative colitis	7.04e-05	0.00049	CcSEcCtD
Risedronate—Paraesthesia—Triamcinolone—ulcerative colitis	7.01e-05	0.000488	CcSEcCtD
Risedronate—Paraesthesia—Methylprednisolone—ulcerative colitis	7e-05	0.000487	CcSEcCtD
Risedronate—Anaemia—Prednisone—ulcerative colitis	6.99e-05	0.000487	CcSEcCtD
Risedronate—Shock—Dexamethasone—ulcerative colitis	6.97e-05	0.000485	CcSEcCtD
Risedronate—Shock—Betamethasone—ulcerative colitis	6.97e-05	0.000485	CcSEcCtD
Risedronate—Dyspnoea—Triamcinolone—ulcerative colitis	6.96e-05	0.000485	CcSEcCtD
Risedronate—Nervous system disorder—Betamethasone—ulcerative colitis	6.95e-05	0.000484	CcSEcCtD
Risedronate—Nervous system disorder—Dexamethasone—ulcerative colitis	6.95e-05	0.000484	CcSEcCtD
Risedronate—Nausea—Mesalazine—ulcerative colitis	6.93e-05	0.000482	CcSEcCtD
Risedronate—Angioedema—Prednisone—ulcerative colitis	6.91e-05	0.000481	CcSEcCtD
Risedronate—Dyspepsia—Triamcinolone—ulcerative colitis	6.87e-05	0.000479	CcSEcCtD
Risedronate—Dyspepsia—Methylprednisolone—ulcerative colitis	6.86e-05	0.000478	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—CRP—ulcerative colitis	6.83e-05	0.0226	CbGpPWpGaD
Risedronate—Vertigo—Prednisone—ulcerative colitis	6.79e-05	0.000473	CcSEcCtD
Risedronate—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	6.78e-05	0.000472	CcSEcCtD
Risedronate—Syncope—Prednisone—ulcerative colitis	6.78e-05	0.000472	CcSEcCtD
Risedronate—Urticaria—Prednisolone—ulcerative colitis	6.75e-05	0.00047	CcSEcCtD
Risedronate—Fatigue—Triamcinolone—ulcerative colitis	6.73e-05	0.000469	CcSEcCtD
Risedronate—Fatigue—Methylprednisolone—ulcerative colitis	6.72e-05	0.000468	CcSEcCtD
Risedronate—Pain—Triamcinolone—ulcerative colitis	6.68e-05	0.000465	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—ulcerative colitis	6.65e-05	0.000463	CcSEcCtD
Risedronate—Urticaria—Hydrocortisone—ulcerative colitis	6.59e-05	0.000459	CcSEcCtD
Risedronate—Abdominal pain—Hydrocortisone—ulcerative colitis	6.56e-05	0.000456	CcSEcCtD
Risedronate—Body temperature increased—Hydrocortisone—ulcerative colitis	6.56e-05	0.000456	CcSEcCtD
Risedronate—Hypertension—Prednisone—ulcerative colitis	6.53e-05	0.000455	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	6.46e-05	0.000449	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	6.46e-05	0.000449	CcSEcCtD
Risedronate—Myalgia—Prednisone—ulcerative colitis	6.44e-05	0.000448	CcSEcCtD
Risedronate—Arthralgia—Prednisone—ulcerative colitis	6.44e-05	0.000448	CcSEcCtD
Risedronate—Anxiety—Prednisone—ulcerative colitis	6.42e-05	0.000447	CcSEcCtD
Risedronate—Insomnia—Betamethasone—ulcerative colitis	6.41e-05	0.000446	CcSEcCtD
Risedronate—Insomnia—Dexamethasone—ulcerative colitis	6.41e-05	0.000446	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	6.39e-05	0.000445	CcSEcCtD
Risedronate—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	6.37e-05	0.000444	CcSEcCtD
Risedronate—Paraesthesia—Betamethasone—ulcerative colitis	6.36e-05	0.000443	CcSEcCtD
Risedronate—Paraesthesia—Dexamethasone—ulcerative colitis	6.36e-05	0.000443	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—ulcerative colitis	6.26e-05	0.000436	CcSEcCtD
Risedronate—Dyspepsia—Betamethasone—ulcerative colitis	6.24e-05	0.000434	CcSEcCtD
Risedronate—Dyspepsia—Dexamethasone—ulcerative colitis	6.24e-05	0.000434	CcSEcCtD
Risedronate—Urticaria—Triamcinolone—ulcerative colitis	6.2e-05	0.000432	CcSEcCtD
Risedronate—Urticaria—Methylprednisolone—ulcerative colitis	6.19e-05	0.000431	CcSEcCtD
Risedronate—Body temperature increased—Triamcinolone—ulcerative colitis	6.17e-05	0.00043	CcSEcCtD
Risedronate—Abdominal pain—Methylprednisolone—ulcerative colitis	6.16e-05	0.000429	CcSEcCtD
Risedronate—Infection—Prednisone—ulcerative colitis	6.13e-05	0.000427	CcSEcCtD
Risedronate—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	6.12e-05	0.000426	CcSEcCtD
Risedronate—Gastrointestinal disorder—Betamethasone—ulcerative colitis	6.12e-05	0.000426	CcSEcCtD
Risedronate—Hypersensitivity—Hydrocortisone—ulcerative colitis	6.11e-05	0.000425	CcSEcCtD
Risedronate—Fatigue—Betamethasone—ulcerative colitis	6.11e-05	0.000425	CcSEcCtD
Risedronate—Fatigue—Dexamethasone—ulcerative colitis	6.11e-05	0.000425	CcSEcCtD
Risedronate—Shock—Prednisone—ulcerative colitis	6.07e-05	0.000423	CcSEcCtD
Risedronate—Pain—Dexamethasone—ulcerative colitis	6.06e-05	0.000422	CcSEcCtD
Risedronate—Pain—Betamethasone—ulcerative colitis	6.06e-05	0.000422	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—ulcerative colitis	6.05e-05	0.000421	CcSEcCtD
Risedronate—Skin disorder—Prednisone—ulcerative colitis	5.99e-05	0.000417	CcSEcCtD
Risedronate—Asthenia—Hydrocortisone—ulcerative colitis	5.95e-05	0.000414	CcSEcCtD
Risedronate—Pruritus—Hydrocortisone—ulcerative colitis	5.87e-05	0.000409	CcSEcCtD
Risedronate—Gastrointestinal pain—Dexamethasone—ulcerative colitis	5.79e-05	0.000403	CcSEcCtD
Risedronate—Gastrointestinal pain—Betamethasone—ulcerative colitis	5.79e-05	0.000403	CcSEcCtD
Risedronate—Hypersensitivity—Triamcinolone—ulcerative colitis	5.75e-05	0.000401	CcSEcCtD
Risedronate—Hypersensitivity—Methylprednisolone—ulcerative colitis	5.74e-05	0.0004	CcSEcCtD
Risedronate—Diarrhoea—Hydrocortisone—ulcerative colitis	5.68e-05	0.000395	CcSEcCtD
Risedronate—Urticaria—Dexamethasone—ulcerative colitis	5.63e-05	0.000392	CcSEcCtD
Risedronate—Urticaria—Betamethasone—ulcerative colitis	5.63e-05	0.000392	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—ulcerative colitis	5.62e-05	0.000391	CcSEcCtD
Risedronate—Dizziness—Prednisolone—ulcerative colitis	5.62e-05	0.000391	CcSEcCtD
Risedronate—Asthenia—Triamcinolone—ulcerative colitis	5.6e-05	0.00039	CcSEcCtD
Risedronate—Abdominal pain—Dexamethasone—ulcerative colitis	5.6e-05	0.00039	CcSEcCtD
Risedronate—Body temperature increased—Dexamethasone—ulcerative colitis	5.6e-05	0.00039	CcSEcCtD
Risedronate—Abdominal pain—Betamethasone—ulcerative colitis	5.6e-05	0.00039	CcSEcCtD
Risedronate—Body temperature increased—Betamethasone—ulcerative colitis	5.6e-05	0.00039	CcSEcCtD
Risedronate—Asthenia—Methylprednisolone—ulcerative colitis	5.59e-05	0.000389	CcSEcCtD
Risedronate—Insomnia—Prednisone—ulcerative colitis	5.58e-05	0.000389	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—ulcerative colitis	5.54e-05	0.000386	CcSEcCtD
Risedronate—Pruritus—Triamcinolone—ulcerative colitis	5.53e-05	0.000385	CcSEcCtD
Risedronate—Pruritus—Methylprednisolone—ulcerative colitis	5.51e-05	0.000384	CcSEcCtD
Risedronate—PTGS2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	5.51e-05	0.0182	CbGpPWpGaD
Risedronate—Dizziness—Hydrocortisone—ulcerative colitis	5.48e-05	0.000382	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—ulcerative colitis	5.43e-05	0.000378	CcSEcCtD
Risedronate—Rash—Prednisolone—ulcerative colitis	5.35e-05	0.000373	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—ulcerative colitis	5.35e-05	0.000372	CcSEcCtD
Risedronate—Diarrhoea—Methylprednisolone—ulcerative colitis	5.33e-05	0.000371	CcSEcCtD
Risedronate—Fatigue—Prednisone—ulcerative colitis	5.32e-05	0.00037	CcSEcCtD
Risedronate—Headache—Prednisolone—ulcerative colitis	5.32e-05	0.00037	CcSEcCtD
Risedronate—Constipation—Prednisone—ulcerative colitis	5.28e-05	0.000367	CcSEcCtD
Risedronate—Vomiting—Hydrocortisone—ulcerative colitis	5.27e-05	0.000367	CcSEcCtD
Risedronate—Rash—Hydrocortisone—ulcerative colitis	5.23e-05	0.000364	CcSEcCtD
Risedronate—Dermatitis—Hydrocortisone—ulcerative colitis	5.23e-05	0.000364	CcSEcCtD
Risedronate—Headache—Hydrocortisone—ulcerative colitis	5.2e-05	0.000362	CcSEcCtD
Risedronate—Dizziness—Triamcinolone—ulcerative colitis	5.16e-05	0.00036	CcSEcCtD
Risedronate—Dizziness—Methylprednisolone—ulcerative colitis	5.15e-05	0.000359	CcSEcCtD
Risedronate—Asthenia—Dexamethasone—ulcerative colitis	5.08e-05	0.000354	CcSEcCtD
Risedronate—Asthenia—Betamethasone—ulcerative colitis	5.08e-05	0.000354	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—ulcerative colitis	5.05e-05	0.000351	CcSEcCtD
Risedronate—Nausea—Prednisolone—ulcerative colitis	5.04e-05	0.000351	CcSEcCtD
Risedronate—Pruritus—Betamethasone—ulcerative colitis	5.01e-05	0.000349	CcSEcCtD
Risedronate—Pruritus—Dexamethasone—ulcerative colitis	5.01e-05	0.000349	CcSEcCtD
Risedronate—Vomiting—Triamcinolone—ulcerative colitis	4.97e-05	0.000346	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CALM3—ulcerative colitis	4.96e-05	0.0164	CbGpPWpGaD
Risedronate—Vomiting—Methylprednisolone—ulcerative colitis	4.95e-05	0.000345	CcSEcCtD
Risedronate—Nausea—Hydrocortisone—ulcerative colitis	4.93e-05	0.000343	CcSEcCtD
Risedronate—Rash—Triamcinolone—ulcerative colitis	4.92e-05	0.000343	CcSEcCtD
Risedronate—Dermatitis—Triamcinolone—ulcerative colitis	4.92e-05	0.000343	CcSEcCtD
Risedronate—Rash—Methylprednisolone—ulcerative colitis	4.91e-05	0.000342	CcSEcCtD
Risedronate—Dermatitis—Methylprednisolone—ulcerative colitis	4.91e-05	0.000342	CcSEcCtD
Risedronate—Urticaria—Prednisone—ulcerative colitis	4.9e-05	0.000341	CcSEcCtD
Risedronate—Headache—Triamcinolone—ulcerative colitis	4.89e-05	0.000341	CcSEcCtD
Risedronate—Headache—Methylprednisolone—ulcerative colitis	4.88e-05	0.00034	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—ulcerative colitis	4.88e-05	0.00034	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—ulcerative colitis	4.88e-05	0.00034	CcSEcCtD
Risedronate—Diarrhoea—Betamethasone—ulcerative colitis	4.85e-05	0.000338	CcSEcCtD
Risedronate—Diarrhoea—Dexamethasone—ulcerative colitis	4.85e-05	0.000338	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—ulcerative colitis	4.81e-05	0.0159	CbGpPWpGaD
Risedronate—Dizziness—Dexamethasone—ulcerative colitis	4.69e-05	0.000326	CcSEcCtD
Risedronate—Dizziness—Betamethasone—ulcerative colitis	4.69e-05	0.000326	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—MIF—ulcerative colitis	4.64e-05	0.0154	CbGpPWpGaD
Risedronate—Nausea—Triamcinolone—ulcerative colitis	4.64e-05	0.000323	CcSEcCtD
Risedronate—Nausea—Methylprednisolone—ulcerative colitis	4.63e-05	0.000322	CcSEcCtD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—ulcerative colitis	4.56e-05	0.0151	CbGpPWpGaD
Risedronate—Hypersensitivity—Prednisone—ulcerative colitis	4.55e-05	0.000317	CcSEcCtD
Risedronate—Vomiting—Dexamethasone—ulcerative colitis	4.51e-05	0.000314	CcSEcCtD
Risedronate—Vomiting—Betamethasone—ulcerative colitis	4.51e-05	0.000314	CcSEcCtD
Risedronate—Rash—Dexamethasone—ulcerative colitis	4.47e-05	0.000311	CcSEcCtD
Risedronate—Rash—Betamethasone—ulcerative colitis	4.47e-05	0.000311	CcSEcCtD
Risedronate—Dermatitis—Dexamethasone—ulcerative colitis	4.46e-05	0.000311	CcSEcCtD
Risedronate—Dermatitis—Betamethasone—ulcerative colitis	4.46e-05	0.000311	CcSEcCtD
Risedronate—Headache—Dexamethasone—ulcerative colitis	4.44e-05	0.000309	CcSEcCtD
Risedronate—Headache—Betamethasone—ulcerative colitis	4.44e-05	0.000309	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—CXCL8—ulcerative colitis	4.44e-05	0.0147	CbGpPWpGaD
Risedronate—Asthenia—Prednisone—ulcerative colitis	4.43e-05	0.000308	CcSEcCtD
Risedronate—Pruritus—Prednisone—ulcerative colitis	4.37e-05	0.000304	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—ulcerative colitis	4.22e-05	0.000294	CcSEcCtD
Risedronate—Nausea—Betamethasone—ulcerative colitis	4.21e-05	0.000293	CcSEcCtD
Risedronate—Nausea—Dexamethasone—ulcerative colitis	4.21e-05	0.000293	CcSEcCtD
Risedronate—Dizziness—Prednisone—ulcerative colitis	4.08e-05	0.000284	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	4.03e-05	0.0133	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—MPO—ulcerative colitis	3.95e-05	0.0131	CbGpPWpGaD
Risedronate—Vomiting—Prednisone—ulcerative colitis	3.92e-05	0.000273	CcSEcCtD
Risedronate—Rash—Prednisone—ulcerative colitis	3.89e-05	0.000271	CcSEcCtD
Risedronate—Dermatitis—Prednisone—ulcerative colitis	3.89e-05	0.000271	CcSEcCtD
Risedronate—Headache—Prednisone—ulcerative colitis	3.87e-05	0.000269	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—MPO—ulcerative colitis	3.81e-05	0.0126	CbGpPWpGaD
Risedronate—Nausea—Prednisone—ulcerative colitis	3.67e-05	0.000255	CcSEcCtD
Risedronate—FDPS—Metabolism—CHP1—ulcerative colitis	3.51e-05	0.0116	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—PTGS1—ulcerative colitis	3.5e-05	0.0116	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—ulcerative colitis	3.4e-05	0.0113	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.29e-05	0.0109	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—ulcerative colitis	3.09e-05	0.0102	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—FCGR2A—ulcerative colitis	3.05e-05	0.0101	CbGpPWpGaD
Risedronate—FDPS—Metabolism—DLD—ulcerative colitis	3.03e-05	0.01	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	3.02e-05	0.01	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	2.68e-05	0.00889	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	2.49e-05	0.00826	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	2.32e-05	0.00769	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	2.2e-05	0.00729	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	2.11e-05	0.00701	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	2.05e-05	0.00678	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	2e-05	0.00663	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	1.96e-05	0.00649	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	1.96e-05	0.00648	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	1.84e-05	0.0061	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	1.67e-05	0.00554	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.6e-05	0.0053	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	1.53e-05	0.00508	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	1.52e-05	0.00505	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	1.52e-05	0.00503	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS1—ulcerative colitis	1.46e-05	0.00485	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	1.46e-05	0.00482	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.44e-05	0.00477	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	1.42e-05	0.00472	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	1.4e-05	0.00465	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	1.4e-05	0.00464	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	1.38e-05	0.00458	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	1.32e-05	0.00437	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CALM3—ulcerative colitis	1.32e-05	0.00437	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.26e-05	0.00417	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	1.25e-05	0.00414	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	1.17e-05	0.00386	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	1.11e-05	0.00367	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	1.03e-05	0.00341	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCB1—ulcerative colitis	1.02e-05	0.00339	CbGpPWpGaD
Risedronate—PTGS2—Disease—CHP1—ulcerative colitis	1e-05	0.00332	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	9.88e-06	0.00327	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	9.84e-06	0.00326	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADCY5—ulcerative colitis	9.56e-06	0.00317	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	9.31e-06	0.00309	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	9.06e-06	0.003	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CHP1—ulcerative colitis	8.4e-06	0.00278	CbGpPWpGaD
Risedronate—PTGS2—Disease—SEL1L—ulcerative colitis	7.97e-06	0.00264	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.87e-06	0.00261	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	7.68e-06	0.00254	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	7.32e-06	0.00242	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DLD—ulcerative colitis	7.25e-06	0.0024	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	7.17e-06	0.00237	CbGpPWpGaD
Risedronate—PTGS2—Disease—LTF—ulcerative colitis	7.15e-06	0.00237	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—ulcerative colitis	7.13e-06	0.00236	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—ulcerative colitis	6.41e-06	0.00212	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	6.32e-06	0.00209	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	6.27e-06	0.00208	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	5.78e-06	0.00192	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—ulcerative colitis	5.61e-06	0.00186	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	5.22e-06	0.00173	CbGpPWpGaD
Risedronate—PTGS2—Disease—SLC11A1—ulcerative colitis	5.09e-06	0.00169	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	4.88e-06	0.00162	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAML2—ulcerative colitis	4.58e-06	0.00152	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	4.3e-06	0.00142	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.83e-06	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Disease—CALM3—ulcerative colitis	3.77e-06	0.00125	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTGS1—ulcerative colitis	3.51e-06	0.00116	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.45e-06	0.00114	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CALM3—ulcerative colitis	3.16e-06	0.00105	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADCY5—ulcerative colitis	2.73e-06	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCB1—ulcerative colitis	2.45e-06	0.000813	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADCY5—ulcerative colitis	2.29e-06	0.000758	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—ulcerative colitis	1.71e-06	0.000566	CbGpPWpGaD
Risedronate—PTGS2—Disease—JAK2—ulcerative colitis	1.7e-06	0.000565	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—ulcerative colitis	1.62e-06	0.000535	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—ulcerative colitis	1.54e-06	0.000509	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—ulcerative colitis	1.25e-06	0.000414	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—ulcerative colitis	1.16e-06	0.000384	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—ulcerative colitis	8.74e-07	0.000289	CbGpPWpGaD
